'No hospital admissions' due to Covid in Oxford trial

Professor Jonathan Van-Tam, England's deputy chief medical officer, explained what made the Oxford University and AstraZeneca vaccine stand out.

The developers are applying for regulatory approval after trial results showed it protected 70% of people.

Analysis also suggests that adjusting the dosage could see the vaccine's effectiveness rise to 90%.

  • UK